Home > Healthcare > Biotechnology > Biotechnology R&D > Biological Sample Collection Kits Market

Biological Sample Collection Kits Market Size

Report ID: GMI6002
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Biological Sample Collection Kits Market Size

Biological Sample Collection Kits Market size was valued at USD 8.4 billion in 2023 and is expected to exhibit growth at a CAGR of 8.8% from 2024 to 2032, driven by the increasing number of laboratory tests, fueled by rising chronic and infectious disease prevalence, advancements in diagnostic technologies, and a growing emphasis on personalized medicine.

To get key market trends

Download Free Sample

Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring, which drives demand for diagnostic tests. As healthcare providers, researchers, and diagnostic labs seek reliable, efficient, and high-quality kits to meet these expanding needs, the market continues to experience robust growth. Biological sample collection kits are specialized tools designed to safely and effectively collect, preserve, and transport biological specimens for laboratory analysis. These kits play a vital role in biomedical research, clinical diagnostics, and healthcare settings, where precise and reliable sample analysis is crucial for accurate results and effective patient care.

Biological Sample Collection Kits Market Report Attributes
Report Attribute	Details
Base Year:	2023
Biological Sample Collection Kits Market Size in 2023:	USD 8.4 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	8.8%
2032 Value Projection:	USD 17.9 Billion
Historical Data for:	2021 - 2023
No. of Pages:	100
Tables, Charts & Figures:	159
Segments covered:	Product, Application, End-use, and Region
Growth Drivers:	Increasing number of laboratory tests Rising usage of lab tests for precise disease diagnosis Growing R&D activities and technological advancements in sample collection techniques Expansion of biobanking and personalized medicine
Pitfalls & Challenges:	High cost of advanced kits and complexities associated with specimen collection

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global biological sample collection kits industry was valued at USD 8.4 billion in 2023 and is expected to exhibit a CAGR of 8.8% from 2024 to 2032, driven by the increasing number of laboratory tests, fueled by rising chronic and infectious disease prevalence.

The hospitals and clinics segment is expected to grow at a pace of 8.7% between 2024-2032, as these settings experience a high volume of patient visits for a range of health issues, including acute and chronic conditions, routine check-ups, surgeries, and emergencies.

North America biological sample collection kits market accounted for USD 2.7 billion in 2023 and is anticipated to record a CAGR of 8.1% through 2032, owing to a high prevalence of chronic diseases, along with focus on regular monitoring and diagnostic testing.

Altona Diagnostics GmbH, Becton, Dickinson and Company, CTK Biotech, Inc., F. Hoffmann-La Roche Ltd, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., and Puritan Medical Products among others.